|
1
|
Chen YF, Luo RZ, Li Y, et al: High
expression levels of COX-2 and P300 are associated with unfavorable
survival in laryngeal squamous cell carcinoma. Eur Arch
Otorhinolaryngol. 270:1009–1017. 2013. View Article : Google Scholar :
|
|
2
|
Chu EA and Kim YJ: Laryngeal cancer:
diagnosis and preoperative work-up. Otolaryngol Clin North Am.
41:673–695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang TC and Mendell JT: microRNAs in
vertebrate physiology and human disease. Annu Rev Genomics Hum
Genet. 8:215–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Latronico MV, Catalucci D and Condorelli
G: Emerging role of microRNAs in cardiovascular biology. Circ Res.
101:1225–1236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ergun S, Arman K, Temiz E, et al:
Expression patterns of miR-221 and its target caspase-3 in
different cancer cell lines. Mol Biol Rep. 41:5877–5881. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ciafrè SA, Galardi S, Mangiola A, et al:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gottardo F, Liu CG, Ferracin M, et al:
MicroRNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He H, Jazdzewski K, Li W, et al: The role
of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad
Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Medina R, Zaidi SK, Liu CG, et al:
MicroRNAs 221 and 222 bypass quiescence and compromise cell
survival. Cancer Res. 68:2773–2780. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
le Sage C, Nagel R, Egan DA, et al:
Regulation of the p27Kip1 tumor suppressor by miR-221
and miR-222 promotes cancer cell proliferation. EMBO J.
26:3699–3708. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gramantieri L, Fornari F, Ferracin M, et
al: MicroRNA-221 targets Bmf in hepatocellular carcinoma and
correlates with tumor multifocality. Clin Cancer Res. 15:5073–5081.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu X, Wang Q, Chen J, et al: Clinical
significance of miR-221 and its inverse correlation with
p27Kip1 in hepatocellular carcinoma. Mol Biol Rep.
38:3029–3035. 2011. View Article : Google Scholar
|
|
13
|
Visone R, Russo L, Pallante P, et al:
MicroRNAs (miR)-221 and miR-222, both overexpressed in human
thyroid papillary carcinomas, regulate p27Kip1 protein
levels and cell cycle. Endocr Relat Cancer. 14:791–798. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gillies JK and Lorimer IA: Regulation of
p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle.
6:2005–2009. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ahmed FE, Jeffries CD, Vos PW, et al:
Diagnostic microRNA markers for screening sporadic human colon
cancer and active ulcerative colitis in stool and tissue. Cancer
Genomics Proteomics. 6:281–295. 2009.PubMed/NCBI
|
|
16
|
Felli N, Fontana L, Pelosi E, et al:
MicroRNAs 221 and 222 inhibit normal erythropoiesis and
erythroleukemic cell growth via kit receptor down-modulation. Proc
Natl Acad Sci USA. 102:18081–18086. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park JK, Kogure T, Nuovo GJ, et al:
miR-221 silencing blocks hepatocellular carcinoma and promotes
survival. Cancer Res. 71:7608–7616. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li P, Nijhawan D, Budihardjo I, et al:
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9
complex initiates an apoptotic protease cascade. Cell. 91:479–489.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lian S, Shi R, Bai T, et al:
Anti-miRNA-23a oligonucleotide suppresses glioma cells growth by
targeting apoptotic protease-activating factor-1. Curr Pharm Des.
19:6382–6389. 2013. View Article : Google Scholar
|
|
20
|
Zang YS, Zhong YF, Fang Z, et al: MiR-155
inhibits the sensitivity of lung cancer cells to cisplatin via
negative regulation of Apaf-1 expression. Cancer Gene Ther.
19:773–778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paik SS, Jang KS, Song YS, et al: Reduced
expression of Apaf-1 in colorectal adenocarcinoma correlates with
tumor progression and aggressive phenotype. Ann Surg Oncol.
14:3453–3459. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Zhang J, Han L, et al:
Downregulation of miR-221/222 sensitizes glioma cells to
temozolomide by regulating apoptosis independently of p53 status.
Oncol Rep. 27:854–860. 2012.
|
